JESS Taylor, CEO of Australian endometriosis patient support group Qendo, has been named the Emerging Leader of the Year at the 2025 Women Changing the World Awards.
The international awards honour women who make outstanding contributions across health, sustainability, humanitarian work, leadership, advocacy, tech, and more.
Qendo's recent campaign for greater access to affordable endometriosis treatments and contraception came to fruition with the progestogen-only pill Slinda and endometriosis drug Ryeqo listed on the PBS from 01 Apr (PD 17 Mar).
Taylor said she will continue to focus on scaling Qendo's national support services and leading systemic reform in how we diagnose, treat and talk about pelvic pain.
The above article was sent to subscribers in Pharmacy Daily's issue from 23 Apr 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 23 Apr 25
